IL252368B - 2-(5,1-dimethyl-3-phenyl-h1-pyrrol-2-yl)-n-(4-(4-(5-fluoropyrimidin-2-yl)piperazin-1-yl)phenyl)-2- Oxacetamide and pharmaceutical preparations containing it - Google Patents

2-(5,1-dimethyl-3-phenyl-h1-pyrrol-2-yl)-n-(4-(4-(5-fluoropyrimidin-2-yl)piperazin-1-yl)phenyl)-2- Oxacetamide and pharmaceutical preparations containing it

Info

Publication number
IL252368B
IL252368B IL252368A IL25236817A IL252368B IL 252368 B IL252368 B IL 252368B IL 252368 A IL252368 A IL 252368A IL 25236817 A IL25236817 A IL 25236817A IL 252368 B IL252368 B IL 252368B
Authority
IL
Israel
Prior art keywords
phenyl
oxoacetamide
fluoropyrimidin
pyrrol
piperazin
Prior art date
Application number
IL252368A
Other languages
English (en)
Hebrew (he)
Other versions
IL252368A0 (en
Original Assignee
F2G Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1420743.5A external-priority patent/GB201420743D0/en
Priority claimed from GBGB1505891.0A external-priority patent/GB201505891D0/en
Application filed by F2G Ltd filed Critical F2G Ltd
Publication of IL252368A0 publication Critical patent/IL252368A0/en
Publication of IL252368B publication Critical patent/IL252368B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01GHORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING
    • A01G7/00Botany in general
    • A01G7/06Treatment of growing trees or plants, e.g. for preventing decay of wood, for tingeing flowers or wood, for prolonging the life of plants
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/601,4-Diazines; Hydrogenated 1,4-diazines
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002Heterocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Zoology (AREA)
  • Pest Control & Pesticides (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Forests & Forestry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Ecology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL252368A 2014-11-21 2017-05-18 2-(5,1-dimethyl-3-phenyl-h1-pyrrol-2-yl)-n-(4-(4-(5-fluoropyrimidin-2-yl)piperazin-1-yl)phenyl)-2- Oxacetamide and pharmaceutical preparations containing it IL252368B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1420743.5A GB201420743D0 (en) 2014-11-21 2014-11-21 Antifungal agents
GBGB1505891.0A GB201505891D0 (en) 2015-04-07 2015-04-07 Antifungal agents
PCT/GB2015/053546 WO2016079536A1 (en) 2014-11-21 2015-11-20 Antifungal agents

Publications (2)

Publication Number Publication Date
IL252368A0 IL252368A0 (en) 2017-07-31
IL252368B true IL252368B (en) 2020-04-30

Family

ID=54704024

Family Applications (1)

Application Number Title Priority Date Filing Date
IL252368A IL252368B (en) 2014-11-21 2017-05-18 2-(5,1-dimethyl-3-phenyl-h1-pyrrol-2-yl)-n-(4-(4-(5-fluoropyrimidin-2-yl)piperazin-1-yl)phenyl)-2- Oxacetamide and pharmaceutical preparations containing it

Country Status (20)

Country Link
US (3) US10201524B2 (cg-RX-API-DMAC7.html)
EP (2) EP3415511A1 (cg-RX-API-DMAC7.html)
JP (1) JP6681894B2 (cg-RX-API-DMAC7.html)
KR (1) KR102550341B1 (cg-RX-API-DMAC7.html)
CN (2) CN111096967B (cg-RX-API-DMAC7.html)
AU (1) AU2015348043B2 (cg-RX-API-DMAC7.html)
BR (1) BR112017010439B1 (cg-RX-API-DMAC7.html)
CA (1) CA2982660C (cg-RX-API-DMAC7.html)
CY (1) CY1120907T1 (cg-RX-API-DMAC7.html)
DK (1) DK3221308T3 (cg-RX-API-DMAC7.html)
ES (1) ES2694637T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20182139T1 (cg-RX-API-DMAC7.html)
IL (1) IL252368B (cg-RX-API-DMAC7.html)
LT (1) LT3221308T (cg-RX-API-DMAC7.html)
MX (1) MX2017006447A (cg-RX-API-DMAC7.html)
PL (1) PL3221308T3 (cg-RX-API-DMAC7.html)
PT (1) PT3221308T (cg-RX-API-DMAC7.html)
RU (1) RU2727520C2 (cg-RX-API-DMAC7.html)
SI (1) SI3221308T1 (cg-RX-API-DMAC7.html)
WO (1) WO2016079536A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
WO2016079536A1 (en) 2014-11-21 2016-05-26 F2G Limited Antifungal agents
US9973887B2 (en) * 2016-01-21 2018-05-15 Google Llc Sharing navigation data among co-located computing devices
TW201735792A (zh) 2016-03-07 2017-10-16 農業保鮮股份有限公司 使用苯并氧雜硼雜環戊烯化合物和防腐氣體作為作物的抗微生物劑之協同方法
GB201609222D0 (en) * 2016-05-25 2016-07-06 F2G Ltd Pharmaceutical formulation
MX2019012116A (es) * 2017-04-10 2019-11-21 Scynexis Inc Agentes antifungicos utilizados en combinacion.
US11834466B2 (en) 2017-11-30 2023-12-05 5Metis, Inc. Benzoxaborole compounds and formulations thereof
BR112021003037A2 (pt) 2018-08-18 2021-05-11 Boragen, Inc. formas sólidas de benzoxaborol substituído e composições do mesmo
US11819503B2 (en) * 2019-04-23 2023-11-21 F2G Ltd Method of treating coccidioides infection
CN115811989A (zh) 2020-05-29 2023-03-17 法国国家科学研究中心 抗真菌前体药物
CN112358974B (zh) * 2020-12-09 2022-06-10 昆明理工大学 一株植物内生真菌黑附球菌fzt214及其应用
CN116675704A (zh) * 2020-12-21 2023-09-01 深圳市祥根生物医药有限公司 一种吡咯衍生物及其制备方法和用途
CN115109040A (zh) * 2021-03-23 2022-09-27 博瑞生物医药(苏州)股份有限公司 抗真菌化合物,包含其的药物组合物和制剂,及其应用
CN113429396A (zh) * 2021-06-08 2021-09-24 深圳市祥根生物医药有限公司 一种五元杂芳环衍生物及其制备方法和用途
TW202521521A (zh) * 2023-08-08 2025-06-01 大陸商上海森輝醫藥有限公司 一種4-苯基哌啶衍生物及其應用

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3202654A (en) 1962-04-27 1965-08-24 Bristol Myers Co 6-[alpha-hydroxy-and alpha-amino-alpha-pyrrolylacetamido] penicillanic acids and salts thereof
GB1051723A (cg-RX-API-DMAC7.html) 1962-04-27
US3252970A (en) 1963-02-27 1966-05-24 Ciba Geigy Corp Aromatization
BE631632A (cg-RX-API-DMAC7.html) 1963-04-26
US3268558A (en) 1964-11-05 1966-08-23 Ortho Pharma Corp 1-r-2, 4-dinitropyrroles
US3458515A (en) 1966-07-21 1969-07-29 American Home Prod Piperazine substituted pyrroles
GB1208014A (en) 1967-03-23 1970-10-07 Glaxo Lab Ltd Cephalosporins
US3573294A (en) 1968-03-14 1971-03-30 Glaxo Lab Ltd 7 - (arylglyoxamido)cephalosporanic acids and their salts and alpha-carbonyl derivatives
BE790747A (fr) 1971-10-30 1973-02-15 Whitefin Holding Sa Stereo-isomeres du 1-(1'-(0-chloro-benzyl)-pyrrol-2'-yl) -2-dibutyl sec.-amino-ethanol et procede pour leur preparation
GB1476503A (en) 1973-06-21 1977-06-16 Sterling Drug Inc 1-arylamino-and 1-arylimino-pyrroles and preparation thereof
BE848465A (fr) 1976-11-18 1977-03-16 Stereo-isomeres de 1-(1'-benzyl-2' pyrryl)-2-disec.butylaminoethanols a activite analgesique et preparations pharmaceutiques qui les contiennent
US4316900A (en) 1977-10-05 1982-02-23 Ciba-Geigy Corporation Piperazinopyrrolobenzodiazepines
JPS57142966A (en) 1981-02-27 1982-09-03 Sagami Chem Res Center (1-alkyl-2-pyrrolyl)glyoxylic acid amide derivative
JPS57144255A (en) 1981-03-03 1982-09-06 Sagami Chem Res Center Alpha-methylthio(1-alkyl-2-pyrrolyl)acetamide derivative
US4761424A (en) 1985-10-01 1988-08-02 Warner-Lambert Company Enolamides, pharmaceutical compositions and methods for treating inflammation
FR2601368B1 (fr) 1986-07-08 1989-04-07 Synthelabo Derives de nitrofuranne, leur preparation et leur application en therapeutique.
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
US5637592A (en) 1994-07-12 1997-06-10 Janssen Pharmaceutica N.V. Acyl derivatives of azolones
MX9700511A (es) 1994-07-21 1997-04-30 Lilly Co Eli Inhibidores de spla2 de indolizina.
DE69632728T2 (de) 1995-04-28 2004-10-14 Banyu Pharmaceutical Co., Ltd. 1,4-disubstituierte piperidinderivate
DE69517160T2 (de) 1995-06-06 2000-11-16 Agfa-Gevaert N.V., Mortsel Photographische Materialien
JPH09249669A (ja) 1996-03-13 1997-09-22 Ono Pharmaceut Co Ltd 縮合ピロール誘導体、およびそれらを有効成分として含有する薬剤
CA2308201C (en) * 1997-10-22 2010-09-28 Jens Ponikau Use of anti-fungal agents for the treatment of fungus-induced mucositis
JP4722288B2 (ja) 1998-06-03 2011-07-13 ジーピーアイ ニル ホールディングス インコーポレイテッド 神経学上の傷害および毛髪損失を治療するために使用されるaza−複素環式化合物
US6331537B1 (en) 1998-06-03 2001-12-18 Gpi Nil Holdings, Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
EE200100575A (et) 1999-05-04 2003-02-17 Janssen Pharmaceutica N.V. Seentevastased eetrid, nende valmistamismeetod jakasutamine, kompositsioon ja selle valmistamismeetod
WO2001008572A1 (de) 1999-07-30 2001-02-08 Norbert Heske Kanülenanordnung zum einbringen endoskopischer instrumente in einen menschlichen oder tierischen körper
GB0011089D0 (en) 2000-05-08 2000-06-28 Black James Foundation Gastrin and cholecystokinin receptor ligands (11)
US7202239B2 (en) 2001-04-12 2007-04-10 Wyeth Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists
US6825201B2 (en) 2001-04-25 2004-11-30 Bristol-Myers Squibb Company Indole, azaindole and related heterocyclic amidopiperazine derivatives
EP1399442B1 (en) 2001-06-06 2006-08-09 Vertex Pharmaceuticals Incorporated Cak inhibitors and uses thereof
ES2389027T3 (es) 2001-06-20 2012-10-22 Daiichi Sankyo Company, Limited Derivados de diamina
TW200306819A (en) 2002-01-25 2003-12-01 Vertex Pharma Indazole compounds useful as protein kinase inhibitors
AU2003217604A1 (en) 2002-02-23 2003-09-09 Bristol-Myers Squibb Company Method of treating hiv infection by preventing interaction of cd4 and gp120
US20050032871A1 (en) 2002-09-03 2005-02-10 Sugen, Inc. Sulfonylated pyrrole-2-indolinone derivatives as kinase inhibitors
CA2517034A1 (en) 2003-03-13 2004-09-30 Synta Pharmaceuticals Corp. Fused pyrrole compounds
RU2006117635A (ru) 2003-10-24 2007-12-10 Шеринг Акциенгезельшафт (De) Производные индолинона и их применение для лечения патологических состояний, таких как злокачественное новообразование
US20060058286A1 (en) 2004-09-16 2006-03-16 Mark Krystal Methods of treating HIV infection
NZ562034A (en) 2005-03-31 2009-10-30 Janssen Pharmaceutica Nv Bicyclic pyrazole compounds as antibacterial agents
AR053713A1 (es) 2005-04-20 2007-05-16 Xenon Pharmaceuticals Inc Compuestos heterociclicos y sus usos como agentes terapeuticos
AU2006248812B2 (en) * 2005-05-18 2012-02-16 F2G Ltd Antifungal agents
US20090176837A1 (en) 2005-07-12 2009-07-09 Sony Corporation Compounds with activity at retinoic acid receptors
WO2007015866A2 (en) 2005-07-20 2007-02-08 Kalypsys, Inc. Inhibitors of p38 kinase and methods of treating inflammatory disorders
US7601844B2 (en) 2006-01-27 2009-10-13 Bristol-Myers Squibb Company Piperidinyl derivatives as modulators of chemokine receptor activity
FR2901144B1 (fr) 2006-05-16 2008-12-26 Diffusion Tech Francaise Sarl Appareils generateur d'aerosols medicaux incluant un dispositif d'amelioration de l'efficacite de depot d'aerosol
WO2008046082A2 (en) 2006-10-12 2008-04-17 Xenon Pharmaceuticals Inc. Use of heterocyclic compounds as therapeutic agents
GB0623209D0 (en) * 2006-11-21 2007-01-03 F2G Ltd Antifungal agents
CN101260086B (zh) 2007-03-06 2011-08-10 中国科学院上海药物研究所 蛋白酪氨酸磷酸酯酶1b抑制剂及其制备方法和用途
GB0710121D0 (en) * 2007-05-25 2007-07-04 F2G Ltd Antifungal agents
CA2720851A1 (en) 2008-04-15 2009-10-22 Schering Corporation Oral pharmaceutical compositions in a molecular solid dispersion
WO2009130481A1 (en) * 2008-04-24 2009-10-29 F2G Ltd Pyrrole antifungal agents
GB0809773D0 (en) * 2008-05-29 2008-07-09 F2G Ltd Antifungal combination therapy
CA2760305A1 (en) 2009-04-28 2010-11-04 Boehringer Ingelheim International Gmbh Ex-vivo treatment of immunological disorders with pkc-theta inhibitors
US20130288956A1 (en) 2010-11-05 2013-10-31 Eisai R&D Management Co., Ltd. Combined pharmaceutical composition as antifungal agent
WO2016079536A1 (en) 2014-11-21 2016-05-26 F2G Limited Antifungal agents

Also Published As

Publication number Publication date
RU2727520C2 (ru) 2020-07-22
CA2982660A1 (en) 2016-05-26
KR20170102241A (ko) 2017-09-08
BR112017010439A2 (pt) 2017-12-26
LT3221308T (lt) 2018-12-27
SI3221308T1 (sl) 2018-12-31
RU2017121370A3 (cg-RX-API-DMAC7.html) 2019-03-28
DK3221308T3 (en) 2018-12-10
IL252368A0 (en) 2017-07-31
PT3221308T (pt) 2018-12-17
PL3221308T3 (pl) 2019-03-29
US20190314333A1 (en) 2019-10-17
KR102550341B1 (ko) 2023-06-30
JP6681894B2 (ja) 2020-04-15
AU2015348043B2 (en) 2019-08-22
US20200179340A1 (en) 2020-06-11
CN111096967B (zh) 2023-03-10
US20170340607A1 (en) 2017-11-30
JP2017536371A (ja) 2017-12-07
WO2016079536A1 (en) 2016-05-26
EP3221308A1 (en) 2017-09-27
CN107207470A (zh) 2017-09-26
CY1120907T1 (el) 2019-12-11
CN107207470B (zh) 2019-12-03
US10201524B2 (en) 2019-02-12
US11065228B2 (en) 2021-07-20
EP3415511A1 (en) 2018-12-19
EP3221308B1 (en) 2018-09-19
BR112017010439B1 (pt) 2023-03-07
MX2017006447A (es) 2018-01-30
RU2017121370A (ru) 2018-12-21
AU2015348043A1 (en) 2017-06-08
CA2982660C (en) 2023-01-24
HRP20182139T1 (hr) 2019-05-03
ES2694637T3 (es) 2018-12-26
CN111096967A (zh) 2020-05-05
US10596150B2 (en) 2020-03-24

Similar Documents

Publication Publication Date Title
IL252368B (en) 2-(5,1-dimethyl-3-phenyl-h1-pyrrol-2-yl)-n-(4-(4-(5-fluoropyrimidin-2-yl)piperazin-1-yl)phenyl)-2- Oxacetamide and pharmaceutical preparations containing it
EP3181559B8 (en) 2-(2,4,5-substituted aniline) pyrimidine derivative, pharmaceutical composition and use thereof
IL247836B (en) 1, 3-benzodioxole derivatives, preparations containing them and their uses
IL252477A0 (en) 2-aminopyrimidine compound, pharmaceutical structure and its use
SI3644999T1 (sl) Sestavki in postopki uporabe 2-(4-klorofenil)-N-((2-(2,6-dioksopiperidin-3-il)-1-oksoizoindolin-5-il) metil)-2,2-difluoroacetamida
IL246987A0 (en) Heteroaryl amides, preparations containing it and their uses
IL252828A0 (en) Piperidine derivative compounds suppressing hdac1/2 preparations containing them and their uses
IL249020B (en) History of (n-(5-amino--1,3,4-thiadiazol-2-yl)-2-(methoxy/ethoxy)-2-phenyl-acetamide and pharmaceutical preparations containing them
MX2020011478A (es) Formas solidas de 2-(4-clorofenil)-n-((2-(2,6-dioxopiperidin-3-il) -1-oxoisoindolin-5-il)metil)-2,2-difluoroacetamida y sus composiciones farmaceuticas y usos.
IL251775A0 (en) 2, 4-converted diaminoquinoline compounds, preparations containing them and their uses
IL248785B (en) Antecedents of ]-n5,1-dimethyl3--oxo-(3,2-dihydro-h1-pyrazol-4-yl)]-methyl-isoxazole-3-carboxamide and pharmaceutical preparations including these antecedents
ZA201804482B (en) Formulations of 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
IL273339A (en) Griseofulbin compound and its medical use
IL252897A0 (en) Indanyl compounds, pharmaceutical preparations and their medical uses
IL247921A0 (en) Glutaminase inhibitor compounds, preparations containing them and their uses
HUE046316T2 (hu) Új 4- (aril) -N- (2-alkoxi-tieno [3,2-B] pirazin-3-il) -piperazin-1-karboxamid-származék és annak antiproliferatív hatása
EP3150587A4 (en) Deuterium substituted 1-[2-(2,4-dimethyl-thiophenyl)-phenyl]piperazine compound or derivative thereof, and pharmaceutical composition and use thereof
IL257621B (en) A catechol derivative and a pharmaceutical preparation that includes it
ZA201902130B (en) Microparticle composition and use thereof
IL246629A0 (en) Pharmaceutical preparations containing a derivative of benzonitrile and gefitinib
EP3227293A4 (en) 6.7-cyclicmorphinan derivatives and use thereof
IL266659B (en) fgfr4 inhibitor, a pharmaceutical preparation containing it and its use
AP2017009706A0 (en) Pharmaceutical compound comprising 13 glycerides, formulation and application thereof
Phillips Conquering Vertigo
HUE052987T2 (hu) ÚJ 4-(aril)-N-(3-alkoxifuro[2,3-B]pirazin-2-il)-piperazin-1-karboxamid-származék antiproliferatív hatással

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed